These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 9293899

  • 1. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM.
    Stem Cells; 1997 Aug; 15(1):18-32. PubMed ID: 9007219
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 7. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE, Foster DC, Lok S, Jacobsen SE, Murphy MJ.
    Stem Cells; 1996 Nov; 14 Suppl 1():163-72. PubMed ID: 11012217
    [Abstract] [Full Text] [Related]

  • 8. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
    LaIuppa JA, Papoutsakis ET, Miller WM.
    Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE, Erickson-Miller CL, Murphy MJ.
    Stem Cells; 1997 Aug; 15(4):286-90. PubMed ID: 9253112
    [Abstract] [Full Text] [Related]

  • 10. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T, Brice M, Farrer D, Kaushansky K.
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [Abstract] [Full Text] [Related]

  • 11. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L, Xiao M, Li ZH, Jolliffe LK, Jones S, Broxmeyer HE, Weich N.
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [Abstract] [Full Text] [Related]

  • 12. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Sep; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y, Takaue Y, Hirao A, Sato J, Abe T, Suzue T, Saito S, Okamoto Y, Kuroda Y.
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [Abstract] [Full Text] [Related]

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 16. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T, Kodama I, Horie K, Kato T, Miyazaki H.
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [Abstract] [Full Text] [Related]

  • 17. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
    Broudy VC, Lin NL, Kaushansky K.
    Blood; 1995 Apr 01; 85(7):1719-26. PubMed ID: 7535585
    [Abstract] [Full Text] [Related]

  • 18. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
    Mitjavila MT, Natazawa M, Brignaschi P, Debili N, Breton-Gorius J, Vainchenker W.
    J Cell Physiol; 1989 Mar 01; 138(3):617-23. PubMed ID: 2647773
    [Abstract] [Full Text] [Related]

  • 19. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
    Rasko JE, O'Flaherty E, Begley CG.
    Stem Cells; 1997 Mar 01; 15(1):33-42. PubMed ID: 9007220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.